Eric Michael Sherb
CIK: 0002090364
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 5 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Sherb Eric Michael
Sherb Eric Michael (SEC CIK 0002090364) files insider reports with the SEC as Chief Financial Officer of Apimeds Pharmaceuticals US, Inc. (APUS), CFO of ROZE AI INC. (ROZE) and Director of Wellgistics Health, Inc. (WGRX). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 5 ownership filings by Sherb Eric Michael, all Form 3s, filed between Oct 23, 2025 and Nov 2, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Sherb Eric Michael's filings is in TAMPA, FL.
Other insiders filing for Apimeds Pharmaceuticals US, Inc. (APUS)
- Menon Vin, Co-Chief Executive Officer
- Inscobee Inc., 10% Owner
- Weintraub Bennett, Director
- Yoon Hankil, Director
- Koo Jakap, Director
- O'DONNELL CAROL A, Director